VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_19-vv-01548 Package ID: USCOURTS-cofc-1_19-vv-01548 Petitioner: Z.K. Filed: 2020-01-21 Decided: 2020-06-29 Vaccine: Tdap Vaccination date: 2018-03-05 Condition: sterile abscess of the left arm Outcome: compensated Award amount USD: AI-assisted case summary: India Washington, mother and natural guardian of Z.K., filed a petition on January 21, 2020, alleging that Z.K. suffered a sterile abscess injury of the left arm caused by a Tetanus-diphtheria-acellular pertussis (Tdap) vaccination administered on March 5, 2018. The respondent, the Secretary of Health and Human Services, filed a report on January 16, 2020, conceding that Z.K.'s medical course was consistent with a sterile abscess in his left upper extremity and that the injury was more likely than not caused by the Tdap vaccine administered in the same location. The respondent also agreed that all legal prerequisites for compensation had been met. Based on the respondent's concession and the evidence of record, Chief Special Master Brian H. Corcoran issued a ruling on entitlement on January 21, 2020, finding Z.K. entitled to compensation. Subsequently, on May 21, 2020, a decision awarding damages was issued based on a stipulation and proffer filed by the parties on May 20, 2020. The parties recommended that compensation be made through future annuity payments, representing all elements of compensation available under the Vaccine Act. The decision awarded an amount sufficient to purchase an annuity contract for Z.K., with specific lump sum payments scheduled for future dates. The public decision does not describe the specific onset of symptoms, medical tests performed, or treatments received. The attorneys involved were Michael M. Bast for the petitioner and Darryl R. Wishard for the respondent. The decision does not name any medical experts. Theory of causation field: Petitioner India Washington, on behalf of minor Z.K., alleged that a Tdap vaccination administered on March 5, 2018, caused a sterile abscess of the left arm. The respondent conceded that Z.K.'s medical course was consistent with a sterile abscess and that the injury was more likely than not caused by the Tdap vaccine. This was a causation-in-fact claim, not a Table injury. The public text does not name any medical experts or describe the specific mechanism of injury. Chief Special Master Brian H. Corcoran issued a ruling on entitlement on January 21, 2020, finding Z.K. entitled to compensation. A damages decision was issued on June 29, 2020, based on a proffer recommending compensation through future annuity payments. The award was an amount sufficient to purchase an annuity contract providing specific lump sum payments on 02/13/2035 ($15,890.33), 02/13/2038 ($17,329.63), and 02/13/2041 ($18,912.52), representing all elements of compensation under 42 U.S.C. § 300aa-15(a). Attorneys for petitioner were Michael M. Bast and for respondent Darryl R. Wishard. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_19-vv-01548-0 Date issued/filed: 2020-02-24 Pages: 2 Docket text: PUBLIC ORDER/RULING (Originally filed: 01/21/2020) regarding 17 Ruling on Entitlement Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made. -------------------------------------------------------------------------------- Case 1:19-vv-01548-UNJ Document 18 Filed 02/24/20 Page 1 of 2 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 19-1548V UNPUBLISHED INDIA WASHINGTON, Mother and Chief Special Master Corcoran Natural Guardian of Infant, Z.K., Filed: January 21, 2020 Petitioner, v. Special Processing Unit (SPU); Ruling on Entitlement; Concession; SECRETARY OF HEALTH AND Causation-In-Fact; Tetanus HUMAN SERVICES, Diphtheria acellular Pertussis (Tdap) Vaccine; Sterile Abscess Respondent. Michael M. Bast, Michael M. Bast PC, Brooklyn, NY, for petitioner. Darryl R. Wishard, U.S. Department of Justice, Washington, DC, for respondent. RULING ON ENTITLEMENT1 On January 15, 2020, India Washington, mother and natural guardian of Z.K., filed an amended petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the “Vaccine Act”). Petitioner alleges that Z.K. suffered sterile abscess injury of the left upper extremity caused-in-fact by a Tetanus-diphtheria-acellular pertussis (“Tdap”) vaccination administered on March 5, 2018. Amended Petition at 10-11. The case was assigned to the Special Processing Unit of the Office of Special Masters. 1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims' website in accordance with the E- Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the ruling will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:19-vv-01548-UNJ Document 18 Filed 02/24/20 Page 2 of 2 On January 16, 2020, Respondent filed his Rule 4(c) report in which he concedes that Petitioner is entitled to compensation in this case. Respondent’s Rule 4(c) Report at 1. Specifically, Respondent has determined that Z.K.’s medical course is consistent with a sterile abscess in his left upper extremity, which was more likely than not caused by administration of a Tdap vaccine in that same location. Id. at 6. Respondent further agrees that Petitioner has satisfied all legal prerequisites for compensation under the Vaccine act. Id. In view of Respondent’s position and the evidence of record, I find that Petitioner is entitled to compensation. IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 2 ================================================================================ DOCUMENT 2: USCOURTS-cofc-1_19-vv-01548-1 Date issued/filed: 2020-06-29 Pages: 5 Docket text: PUBLIC DECISION (Originally filed: 05/21/2020) regarding 22 DECISION Stipulation/Proffer Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made. -------------------------------------------------------------------------------- Case 1:19-vv-01548-UNJ Document 28 Filed 06/29/20 Page 1 of 5 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 19-1548V UNPUBLISHED INDIA WASHINGTON, Mother and Chief Special Master Corcoran Natural Guardian of Infant, Z.K., Filed: May 21, 2020 Petitioner, v. Special Processing Unit (SPU); Damages Decision Based on Proffer; SECRETARY OF HEALTH AND Tetanus Diphtheria acellular HUMAN SERVICES, Pertussis (Tdap) Vaccine; Shoulder Injury Related to Vaccine Respondent. Administration (SIRVA) Michael M. Bast, Michael M. Bast, PC, Brooklyn, NY, for petitioner. Darryl R. Wishard, U.S. Department of Justice, Washington, DC, for respondent. DECISION AWARDING DAMAGES1 On October 3, 2019, India Washington, mother and natural guardian of infant Z.K., filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the “Vaccine Act”). Petitioner alleges that Z.K. suffered shoulder injury related to vaccine administration and a causation-in-fact claim for a sterile abscess of the left arm. Petition at 10-12. The case was assigned to the Special Processing Unit of the Office of Special Masters. On January 21, 2020, a ruling on entitlement was issued, finding Petitioner entitled to compensation for a sterile abscess. On May 20, 2020, Respondent filed a proffer on award of compensation (“Proffer”) indicating Petitioner should be awarded an amount sufficient to purchase the annuity as described in paragraph II.A. of the Proffer. 1 Because this unpublished decision contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims' website in accordance with the E- Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:19-vv-01548-UNJ Document 28 Filed 06/29/20 Page 2 of 5 Proffer at 2. In the Proffer, Respondent represented that Petitioner agrees with the proffered award. Id. Based on the record as a whole, I find that Petitioner is entitled to an award as stated in the Proffer. Pursuant to the terms stated in the attached Proffer, I award Petitioner an amount sufficient to purchase the annuity contract described in Section II.A of the Proffer. This amount represents compensation for all damages that would be available under § 15(a). The clerk of the court is directed to enter judgment in accordance with this decision.3 IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:19-vv-01548-UNJ Document 28 Filed 06/29/20 Page 3 of 5 IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS __________________________________________ ) INDIA WASHINGTON, Mother and ) Natural Guardian of Infant, Z.K., ) ) Petitioner, ) No. 19-1548V ECF ) v. ) Chief Special Master Corcoran ) SECRETARY OF HEALTH AND ) HUMAN SERVICES, ) ) Respondent. ) __________________________________________) RESPONDENT’S PROFFER OF DAMAGES I. Procedural History On October 3, 2019, India Washington (“petitioner”), filed a petition for compensation under the National Vaccine Injury Compensation Act of 1986, 42 U.S.C. §§ 300aa-10 to -34 (“Vaccine Act” or “Act”), as amended. In that petition, petitioner alleged that her child, Z.K. (hereinafter “ZK”), received a tetanus-diphtheria-acellular pertussis (“Tdap”) vaccination in the left arm on March 5, 2018, and suffered a Table injury for shoulder injury related to vaccine administration (“SIRVA”) and a causation-in-fact claim for a sterile abscess of the left arm. See Petition (“Pet.”) at 1, 10-12. On January 15, 2020, petitioner filed an amended petition, alleging only a causation-in-fact for the sterile abscess injury of the left arm. See Amended Pet. at 10-11. On January 16, 2020, respondent filed his Vaccine Rule 4(c) report, conceding that petitioner had satisfied all legal prerequisites for compensation under the Act for a causation-in-fact claim for ZK’s sterile abscess. On January 21, 2020, the Chief Special Master issued a ruling on entitlement, finding that petitioner was entitled to compensation for ZK. 1 Case 1:19-vv-01548-UNJ Document 28 Filed 06/29/20 Page 4 of 5 II. Items of Compensation and Form of the Award Based upon the evidence of record, respondent proffers, and the parties recommend, that compensation be made through future annuity payments as described below, and request that the Chief Special Master’s decision and the Court’s judgment award the following:1 A. Annuity An amount sufficient to purchase an annuity contract,2 paid to the life insurance company3 from which the annuity will be purchased,4 subject to the conditions described below, that will provide payments to ZK as set forth below: 1. $15,890.33 payable in a certain lump sum on 02/13/2035. 2. $17,329.63 payable in a certain lump sum on 02/13/2038. 3. $18,912.52 payable in a certain lump sum on 02/13/2041. 1 Should ZK die prior to entry of judgment, the parties reserve the right to move the Court for appropriate relief. In particular, respondent would oppose any award for future medical expenses, future lost earnings, and future pain and suffering. 2 In respondent’s discretion, respondent may purchase one or more annuity contracts from one or more life insurance companies. 3 The Life Insurance Company must have a minimum of $250,000,000 capital and surplus, exclusive of any mandatory security valuation reserve. The Life Insurance Company must have one of the following ratings from two of the following rating organizations: a. A.M. Best Company: A++, A+, A+g, A+p, A+r, or A+s; b. Moody's Investor Service Claims Paying Rating: Aa3, Aa2, Aa1, or Aaa; c. Standard and Poor's Corporation Insurer Claims-Paying Ability Rating: AA-, AA, AA+, or AAA; d. Fitch Credit Rating Company, Insurance Company Claims Paying Ability Rating: AA-, AA, AA+, or AAA. 4 Petitioner authorizes the disclosure of certain documents filed by the petitioner in this case consistent with the Privacy Act and the routine uses described in the National Vaccine Injury Compensation Program System of Records, No. 09-15-0056. 2 Case 1:19-vv-01548-UNJ Document 28 Filed 06/29/20 Page 5 of 5 Should ZK predecease any of the certain lump sum payments set forth above, said payments shall be made to his estate. Written notice to the Secretary of Health and Human Services and to the Life Insurance Company shall be provided within twenty (20) days of ZK’s death. This amount represents all elements of compensation to which ZK would be entitled under 42 U.S.C. § 300aa-15(a). Petitioner agrees.5 II. Summary of Recommended Payments Following Judgment A. An amount sufficient to purchase the annuity contract described above in section I. A. Respectfully submitted, JOSEPH H. HUNT Assistant Attorney General C. SALVATORE D’ALESSIO Acting Director Torts Branch, Civil Division CATHARINE E. REEVES Deputy Director Torts Branch, Civil Division HEATHER L. PEARLMAN Assistant Director Torts Branch, Civil Division /s/Darryl R. Wishard DARRYL R. WISHARD Senior Trial Attorney Torts Branch, Civil Division U.S. Department of Justice P.O. Box 146 Benjamin Franklin Station Washington, D.C. 20044-0146 Tel: (202) 616-4357 Dated: May 20, 2020 5 At the time payment is received, ZK will be an adult, and thus, a guardianship is not required. 3